Notes

A run was completed early with $235.86 in cash and no eligible trade. WATCH #20 remains in control with no validated edge change. Job #10 was cancelled and replaced with #11, which runs every 240 minutes for 77 times with a 60-second timeout. The new job starts immediately, shifting the schedule from 01:00 UTC. A local script, /tmp/codex-run-eAlvqw/watch-compact.sh, was successful and used the same prior 20 completed closes with no execution eligibility. The script fits all ten names in its output. The first sandbox result will be verified in the next run. The latest daily check on September 3 showed BTC/UNI as true and the other eight as false, with no new daily close yet. The data source is https://runway.adityaperswal.workers.dev/data/crypto-bars. The next research is on September 5 at 00:00 UTC and will include confirming new bar availability, testing net-cost and holdout, and verifying top-volume ranking. No new strategy backtest was performed in this review. Other funds' monitors and lessons were not touched. The journal write was successful.

The automated trading fund manager has completed a review of the system. The manager checked the live memory, ledger, and monitors, and found no positions or pending orders for Catalyst. All trade lessons were saved. There are no new proposals. The manager noted that KR #9 will be activated on September 11 at 12:00 UTC, but the call time is the only reliable timing for an exit, not the monitor release or call shorthand. The next scheduled job is the existing IONS/MIRM informational job #9, which will run at 00:30 UTC. The next research task is to recover original event-test data and code, and to define independent validation before tuning. The manager also needs to report on the out-of-sample payoff distribution and affordable whole-share implementation. A complete company-wide catalyst inventory must be completed before any biotech proposal can be made. The review was finished early, within the 18-minute allowance and 45-minute ceiling, and no unused research time was spent.

A trading review was completed early, within the allowed 18 minutes, and all necessary records were kept. The system checked for any open trades or orders, but found none, and $278.67 was left as cash. No new trades were proposed. The system will use existing rules to guide future trades. On September 5 at 00:00 UTC, the system will review old test scripts and data, and check costs, dividends, and other corporate actions. If some data is still missing, the system will create a new rule before looking at results. A news scan found the link https://www.frontlineplc.cy/fro-second-quarter-and-six-months-2026-results/, but no action was taken based on this information.

A trading review was completed early within the allowed 15 minutes. The system checked its live memory, trades, and monitors, but found no new rules, open or pending orders, or Quant monitor issues, which is a tool that uses mathematical models to analyze data. The system has $245.69 in cash and no proposals for new trades. It applied lesson number 32, which is a set of instructions to improve trading, and saved its observations and strategy analysis. The system will not repeat any forced-trade lessons. The next research task is on September 5 at 00:00 UTC, which is a time zone, to recover some lost data and prepare for a new validation test. The system should not use old notes or job number 8 earnings headlines as a reason to make a trade. The next output for job number 8 is scheduled for September 5 at 06:45, and no other signals need to be watched before then. The next regular stock trading session is on September 8. No new backtest, which is a test of a trading strategy, was performed. The remaining task is to improve the system's ability to make accurate predictions and maximize payoff, not to place orders or access the journal.

The previous decision to hold cash is still in place unless new evidence changes the current rejection, known as rejection number 18. A review of the trading strategy was conducted through September 5 at 00:00 UTC, and no new strategy was implemented. The review started with the least predictable aspects first. There are three main areas of focus: Evidence, Operations, and Implementation. Evidence includes provenance, which is the origin of a fact, validation, which is checking if something is true, and inference, which is making an educated guess. Operations involve exposures, which are current trades, monitors, which are tools to track progress, and continuity, which is ensuring that tasks are completed. Implementation includes sizing, which determines the amount to invest, limits, which set boundaries for investments, and decision, which is choosing what action to take, such as holding cash or conducting further research. A lesson from a previous experience, lesson number 33, reminds us that repeated news headlines cannot change the outcome of a failed test. No changes were made to other funds.

The trading review was done before September 5 00:00 UTC. The review had three main parts: evidence, operations, and economics. Evidence included looking at raw data, costs, and how well the strategy worked. Operations involved checking current trades, monitoring systems, and past lessons. Economics looked at financial results, costs, and the value of the strategy. The review also considered decision-making, including how much to invest and when to take action. The latest information shows that only strategy #13 and #19 are being used, with two closed trades and one monitor completed. No new rules have been validated. Old notes about automatic tanker entries are no longer used.

The prior rule is to stay in cash unless there is recorded evidence that supplies a validated executable rule. The review will reuse question tree number 69, expanding it by three levels. The levels are: (1) Evidence, which includes validation, provenance, and contradictions, such as new adoption, chronological holdout, and net costs, as well as the origin of the data and any potential contradictions like superseded notes; (2) Operations, which includes exposure, monitors, and continuity, like open, pending, and closing positions, as well as ownership and due time; (3) Implementation, which includes sizing, limits, and execution, such as win probability and average win or loss, and whole-share affordability; and (4) Decision, which includes eligibility, handoff, and cost, like changed evidence and avoiding redundant sweeps. The least predictable issue is unexpected exposure or a newly validated rule since 21:06. This review is of existing rules and does not involve mining for new strategies.

A trading review was conducted at 21:18. The review was based on recorded evidence that supersedes WATCH #20, and its purpose was to assess the current state of trading, not to research new strategies. The review started with the least predictable aspects, which included four main areas. The first area was evidence eligibility, which involved validation of new daily holdout, hourly replication, and costs, as well as provenance, which included artifacts, timestamps, and independent windows, and payoffs, which included sample size, win probability, and average win/loss. The second area was operations, which included exposure, such as open, pending, and closing, monitoring, such as due fund monitor, latest job output, and remaining runs, and continuity, such as saved lessons, superseded ADOPT, and the next 00:00 UTC run. The third area was implementation, which included signal, such as completed bar, close field, and rolling 20, execution, such as next-bar timing, 15-minute exits, and spread, and capital, such as fund cap, quarter-Kelly, and 1% equity risk. The fourth area was decision, which included alternative explanations, such as momentum real, historical selection, and execution bias, handoff, such as research-only watch, missing validation, and no duplicate job, and learning, such as apply current lesson, record verdict, and preserve capital. The review did not assume a positive edge from monthly profit pressure.

The fund is currently flat, with no orders proposed or queued. The Chief Investment Officer's ambiguity has been resolved, and the old strategy ADOPT has been downgraded to WATCH, confirming strategy #15. Previous close signals for BTC/UNI are research alerts, not eligible trades. The Alpaca API supports hourly bars, allowing for future research to implement validation without waiting for hourly support. The next research steps include preregistering a rule, implementing a chronological holdout, and tuning using vectorbt with next-bar timing, fees, slippage, and measured-range exits. The research will report on metrics such as return, drawdown, win probability, and average win/loss on daily and hourly bars. Job #10 is active, with the next run scheduled for 01:00 UTC with 77 runs. The latest output has been truncated near XRP, so its output needs to be compacted before relying on complete monitoring. The next run at 00:00 UTC should fetch the newly completed daily bar after confirming availability. No eligible actions exist between runs, and no extra event monitor is warranted. The technical lesson has been saved, with source data in artifacts/market-raw.json and derived fields in artifacts/review.json.

A review was completed at 21:05 on September 4. At 21:07 UTC, the system checked the current supply and found that reads and writes were successful. The book is flat, meaning there are no open orders, and monitor number 4 is done. No action is needed before the next research run at 00:00 UTC on September 5. The system has $278.67 in cash and no proposals. The system applied lessons from prior forced-liquidation events without repeating trade-linked entries. It also added a qualification for the issuer's ballast day and current operational observation. The strategy decision is to reject re-entry until a validated edge is found. Prior notes number 2 and number 8 are no longer valid. The next research task is to recover original holdout scripts and data. If this is not possible, a fresh rule and chronological holdout will be created before inspecting outcomes, using costs, dividend and corporate-action treatment, measured swing exits, loss distribution, and quarter-Kelly, which is a risk management strategy. The system will not reuse previously reported results, such as FRO with a 14.4% gain over 11 trades or STNG with a -0.8% loss over 7 trades, without provenance, meaning without a clear record of how they were obtained. No new monitoring job was added because there is no executable entry signal or open risk. The review was completed early and explicitly identified missing artifact validation, rather than assuming it was complete.

A review of the trading system was completed on September 4 at approximately 21:07 UTC. The system's memory, trades, and monitors were read successfully and all journal entries were written correctly. The Catalyst fund has $49.14 in cash and no open or pending trades, and no monitors are due. The KR system, also known as a trading rule, remains armed and will be triggered on September 11 at 12:00 UTC, with the source verifying the call time, which is the time the trade is made, not the release timestamp, which is the time the trade is announced. No new trading rules or catalysts, which are events that trigger trades, were established. The existing IONS/MIRM job, which is a set of trades, is scheduled to run on September 5 at 00:30 UTC, and the next research run is scheduled for September 5 at 00:00 UTC. There are still some gaps in the system's knowledge, including the exact payoff distribution, which is the range of possible outcomes, and the future presentation date of pelacarsen, a biotech product. The Ionis issuer website could not be reopened, so the system is relying on a previous observation from September 4. No actions were taken in other funds. The review was completed early and all remaining budget was used for the final recording and report phase.

On September 4 at 21:06 UTC, the system reviewed its current trades and monitors. The quant system, which uses mathematical models to make trades, had no open, pending, or closing orders and no monitors active. All lessons from previous trades that were stopped forcefully have been saved, and no new lessons from duplicate trades were added. The latest decision not to trade based on a Price Earnings to Abnormal Returns Diagnosis, or PEAD verdict, still controls the system's actions. Old notes about a Golden Trend Line Break, or GTLB, entry are still not being used. The system will keep $245.69 in cash and not make any new trades. The next update is scheduled for September 5 at 06:45 UTC. There are no new trading signals that need to be acted on before the next research run on September 5 at 00:00 UTC. The system still needs to validate its methods using real data and affordable cash-only trades. Do not assume that the system's size is increasing just because some trades were successful or because of funding pressure. No new test of the system's trading strategy was run. The system successfully wrote its journal entries. Other funds are responsible for their own trades and lessons.

The trading fund manager reviews the current state of trading at 21:05. Unless there is new evidence, the manager starts with no trades. The biggest unknown is whether the old trading decision still works after checking the source of the information. The manager uses a three-part checklist to make decisions: (1) checking the rules, including definitions, validation, and payoff, (2) looking at changes in the market, including operations, data, and signals, such as Bitcoin and Ethereum/Solana, and (3) implementing the plan, including constraints, exits, and continuity, with a budget of $235.86 for the fund and $212.77 for the position, and a risk of $8.5108. The manager decides to stick with the current rules and not look for new reasons to trade or alternative rules. The manager can determine if trading is not allowed without needing to try all possible options.

A trading review was done at 21:05. The review was to check the current state of trading, not to create a new strategy. The review followed a question tree, which is a list of questions to answer in order, starting with the least predictable ones. The questions were: 1 Evidence audit, which includes checking if results can be reproduced, if the conclusions are correct, and if the exits from trades were correct. This includes checking raw data, parameters, and dates when trades were not made. It also includes checking costs, loss distribution, and selection bias. The review also looked at operations, including the current state of trades, pending orders, and the fund's capital. It also checked monitors, such as ownership of supplies, the current state of trades, and required actions. The review also looked at continuity, including saved lessons, old notes, and the next research run. Then it looked at economics, including freight rates, days covered, and how spot and realized rates are defined. It also checked bottlenecks, including beneficiaries, volume destruction, and normalization. The review also looked at sizing, including the probability of winning, average win and loss, and quarter-Kelly and caps. The decision part of the review looked at the source of information, rejection of information, and handoff, which includes recovering artifacts, preregistering the next test, and staying in cash until validation. A lesson from before was applied: just because an operator made money from liquidating a trade, it does not mean the strategy for exiting trades is correct. The initial reads confirmed analysis number 13 and six supply lessons are now saved; the historical statement that reads were empty describes the prior run, not the current availability of data.

A trading fund manager reviewed the current strategy at 21:05 UTC. The manager will keep cash unless new evidence changes the previous analysis, which was rejected in points 6 and 16. The review will continue until the next run on September 5 at 00:00 UTC, and will not involve searching for a new strategy. The manager considered the following questions, starting with the least predictable: (1) Is there new evidence, including (a) news from the issuer, such as timing, endpoint, or future events; (b) validation, including new holdout data, costs, and payoff distribution; and (c) provenance, including the original issuer, repeated reporting, and contradictions. (2) What is the operational exposure, including (a) trades, such as open, pending, or forced exits; (b) monitors, including due, armed, or obsolete ones; and (c) continuity, including watching the job, the next run, and the market session. (3) How can the strategy be implemented, including (a) edge, such as win rate, average win, and average loss, which is a measure of the strategy's effectiveness; (b) size, including a $49.14 cap, whole shares, and gap stress; and (c) decision, including rejecting unchanged entries, preserving a conditional watch, and recording gaps. The manager will reuse existing research and not retune parameters after a failed holdout, which is a test of the strategy's performance on unseen data.

The prior rule was to retain cash unless new evidence changed the decision to reject an investment. The resolution only changed the operational state and previously validated rules, without considering new research. A question tree was used to make a decision, which had three main parts. The first part looked at evidence, including the latest analysis, rejection date, and notes that were no longer valid, as well as the ability to implement a trade with cash only and affordable lots. It also considered the inference, including sample selection, natural versus forced exits, and missing costs. The second part examined the operational state, including current holdings, orders, and monitors, such as fund ownership and due time. The third part made a decision based on sizing, including win probability and average win or loss, as well as constraints, including the fund's value of $245.69, position value of $212.77, and equity risk of $8.5108. The decision also considered continuity, including the next run at 00:00 UTC and research gaps. The least predictable question was whether current records contained any new valid rule or unexpected live exposure.

A research alert was issued for a breakout, which is when a stock or cryptocurrency price moves above a certain level. The alert is based on hourly and cost-adjusted out-of-sample validation, which is a method of testing a model using data it was not trained on. The existing watchlist was used, but the volume ranking was not verified. The data came from https://runway.adityaperswal.workers.dev/data/crypto-bars. The following cryptocurrencies were analyzed: BTC/USD, which closed at $81,269.49 on 2026-09-03, ETH/USD, which closed at $2,508.21 on 2026-09-03, SOL/USD, which closed at $103.97 on 2026-09-03, LTC/USD, which closed at $51.50 on 2026-09-03, UNI/USD, which closed at $6.33 on 2026-09-03, AVAX/USD, which closed at $7.52 on 2026-09-03, DOGE/USD, which closed at $0.088 on 2026-09-03, LINK/USD, which closed at $11.83 on 2026-09-03, and XRP/USD, which closed at $1.45 on 2026-09-03. The completed signal, which indicates whether the breakout condition was met, was true for BTC/USD and UNI/USD, and false for the others. The next close threshold, which is the price level that must be reached for the breakout to be confirmed, was set at $81,269.49 for BTC/USD, $2,515.93 for ETH/USD, $109.15 for SOL/USD, $53.14 for LTC/USD, $6.33 for UNI/USD, $7.83 for AVAX/USD, $0.0934 for DOGE/USD, $11.99 for LINK/USD, and $1.52 for XRP/USD. Execution was not eligible for any of the cryptocurrencies.

A problem was found in an old system, which was using a fixed date of 2026-08-01 and the highest price from all previous days, not a moving 20-day window as intended. The old system also incorrectly labeled this as a '20-day high'. A new system, job #10, has been created to fix this issue. It uses the last 20 days of completed daily closes, excluding the current day, and checks for any missing data. The new system also marks execution as not eligible. The script was tested before being scheduled. This fix supports a previous analysis, #15, and does not change the decision to take no risk.

On September 4, 2026, at approximately 20:55 UTC, there were no new proposals and the $49.14 Catalyst allocation remained in cash. A review of research notes and Catalyst trades was conducted. The KR order set for September 11 at 12:00 UTC remains in place, which is the confirmed call time, not the release timestamp. The existing plan to evaluate guidance and price reaction before making any trades is still in effect. It was confirmed that IONS' pelacarsen failed, as reported by IONS: https://ir.ionis.com/news-releases/news-release-details/ionis-partner-novartis-announces-lpahorizon-phase-3-topline. No future presentation date was provided, so none was added. The existing watch on IONS and MIRM is still active. Lessons were saved for IONS #4 and MIRM #5. All reads and writes were successful this time, with no repeat of the prior 401/approval problem. There was no intervention in other funds' monitors. The next run is at 21:00 UTC, and the next regular equity session is on Tuesday, September 8, not Monday, September 7. Research gaps include no validated positive out-of-sample catalyst edge, no quantified pelacarsen valuation impact, and no future exact presentation date. No new backtest or simulation was needed for the unchanged trading rule.

On September 4, the trading run resulted in no proposals and a flat book, which was verified through a query of trades. Analysis number 15 has suspended the executable status of adopted backtest number 5, pending review of its signal and exit rules, including hourly and daily testing, fees, and metrics. Monitor number 8 was resolved without using an unverified jobs report number. The close-watch script was tested against live data and an old job was replaced with a new research-only watch. The journals are now working and lessons have been saved, including a cryptocurrency trade. The watchlist of ten names was not rechecked for volume. No new strategy research was done during this short trading run. The next researcher should register the validation design before trying different parameters, and no trades will be made until it is validated. The current values and signal comparisons have been saved as observations.

On September 4, 2026, a review of trading activities was conducted, which included research queries, trade queries, monitoring lists, and journal entries, all of which were successful. The review included an analysis of the trading strategy, numbered 14, and lessons learned from quantitative trades, specifically trades numbered 1 for GTLB, 7 for DELL, and 9 for SNOW. Currently, there are no active quantitative trades, pending orders, or monitors. Notes from September 2 regarding GTLB, numbered 4 and 7, should be disregarded as they have been superseded by a decision made on September 4. The cash balance is $245.69, and the proposed risk is zero. The next trading session will require a review of only the changes made, and previously rejected variations should not be re-examined unless new evidence emerges. For the next research session, a test of net costs in chronological order should be preregistered before examining the holdout, using the actual entry and exit rules and considering only cash implementability. A headline job numbered 8 regarding Post-Earnings Announcement Drift, or PEAD, is for informational purposes only and does not authorize an entry. Monitors and lessons from other funds, numbered 6 and 8, are not relevant to this particular set of trades. The next regular trading day for US stocks will be Tuesday, September 8, according to the provided venue calendar, as Monday is not a trading day.

On September 4, 2026, at 20:54 UTC, a review of the trading system was completed. This review replaces old instructions, numbered 2 and 8, which directed the system to automatically buy tanker stocks at the next open and specified the size of these purchases. However, these instructions are now outdated and should not be followed unless a new rule is created that takes into account the cost of buying and selling, and this rule is tested and proven to work. The system currently has $278.67 in cash and there are no open or pending orders, and no active monitoring is taking place, as task number 4 has been completed. The analysis of past trades, recorded as number 13, was successful and lessons learned from trades number 3 and 6 were saved. A previous issue with writing to the system's journal is no longer happening with the current tools. Some past trades, reported as holdouts, have not been reviewed because the necessary information is missing from the live journal. The next step is to recover this missing information, check how the system handles dividends and other corporate actions, set realistic daily targets, and study the distribution of losses and the quarter-Kelly criterion. Having a high number of bookings does not necessarily mean that a stock is a good investment opportunity. No new event monitor or scheduled job is needed at this time, as the trading book is currently flat, and the next review will take place before 21:00 UTC.

Before making a trade, the fund manager remains flat unless there is recorded evidence to support entering a trade. The question tree to consider a trade has four parts. First, the manager checks if the adopted research is executable, which includes defining signals, validating the research, and making inferences based on sample size, win probability, and payoff distribution. Second, the manager checks if a signal is active by looking at the freshness of the data, the completion of daily boundaries, and the presence of missing bars, as well as monitoring a specific technical indicator, called monitor #8. Third, the manager checks if the trade can be sized by considering constraints such as the fund size of $235.86, the position size of $212.77, and the risk of $8.5108, as well as exit strategies like measured range and gap stress. Fourth, the manager considers continuity by reviewing journal writes, monitoring definitions, and handing off to the next run. The focus is on auditing the current strategy and checking its status, without introducing a new macro thesis, as of September 4 at 20:54 UTC.

On September 4, the decision was to hold cash because a rule called the recorded run-up rule failed a test called holdout. The next step is to look at changes that could change this decision before the next review. The team will ignore small changes during the day that are not based on a validated rule. To make a decision, the team uses a question tree with three main questions. The first question is whether the team has enough information to take action, which includes looking at past notes, observations, and analyses, as well as lessons learned from early FDA action, company-wide overlap, and fractional exits, and checking current holdings, pending orders, and monitors. The second question is whether new evidence has come up, including a headline from IONS with confirmation from the primary issuer, event date, and endpoint definitions, earnings information such as the confirmed date, changed timing, and prior information already released, and edge information including holdout return, sample size, and costs. The third question is whether the team can justify taking on more risk, which includes looking at the size of the potential investment, including win probability, payoff ratio, and gap stress, constraints such as the $49.14 in fund capital, whether the team can afford to buy whole shares, and the $8.51 equity loss ceiling, and making a decision, with the rule that there will be no proposal without a positive validated edge, keeping a monitor on KR, and recording lessons from forced exits.

A news scan found the following headlines: On 2026-09-04T15:59:19Z, Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $86 Price Target. On 2026-09-04T15:12:41Z, BMO Capital Maintains Market Perform on Ionis Pharmaceuticals, Raises Price Target to $61. On 2026-09-04T14:23:20Z, Ionis Pharmaceuticals Exec Says Zanvastro Will Be Available At List Price Of $285K Per Dose. On 2026-09-04T12:23:39Z, Ionis Drug Wins FDA Approval as First Alexander Disease Treatment. On 2026-09-04T10:29:48Z, HC Wainwright & Co. Reiterates Buy on Ionis Pharmaceuticals, Maintains $115 Price Target. On 2026-09-03T19:56:03Z, FDA Approves Zanvastro For Treatment Of Alexander Disease. On 2026-08-31T10:26:26Z, HC Wainwright & Co. Reiterates Buy on Ionis Pharmaceuticals, Maintains $115 Price Target. On 2026-08-27T14:01:27Z, Citizens Reiterates Market Outperform on Mirum Pharmaceuticals, Maintains $137 Price Target. On 2026-08-20T16:01:25Z, This Allstate Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday, including Ionis Pharmaceuticals. On 2026-08-20T12:50:45Z, This Merck Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday, including Ionis Pharmaceuticals. On 2026-08-20T11:51:49Z, This Sphere Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday, including Ionis Pharmaceuticals. On 2026-08-19T12:52:50Z, This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday, including Ionis Pharmaceuticals. On 2026-08-19T11:55:12Z, This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday, including Ionis Pharmaceuticals. On 2026-08-19T10:45:21Z, BMO Capital Initiates Coverage On Ionis Pharmaceuticals with Market Perform Rating, Announces Price Target of $60. On 2026-08-18T17:35:20Z, 10 Health Care Stocks Whale Activity In Today’s Session, including Ionis Pharmaceuticals.